Monday, June 16, 2025

Latest

Curaleaf To Enter European Market With US$286 Million Acquisition

Curaleaf Holdings (CSE: CURA) this evening announced that it is making a move into European markets. The US-focused cannabis operator has agreed to acquire that of EMMAC Life Sciences, whom is reportedly the largest vertically integrated independent cannabis firm in Europe.

The acquisition will see Curaleaf pay base consideration of US$286 million, which will see 15% paid in cash, or $42.9 million, while the remainder is to be paid via subordinate voting shares. Contingent consideration of up to $57 million will also be paid in subordinate voting shares and cash at the same ratio.

EMMAC currently has operations across the UK, Germany, Italy, Spain and Portugal, where it currently has cultivation, processing, distribution, and R&D operations. An operational presence is also reportedly in place in several EU nations currently enacting new medical cannabis programs.

The current management team of EMMAC is expected to continue to run the day to day operations of the firm. Plans to expand operations are already underway, with a goal of exceeding ten tons per year of cultivation by 2022 to facilitate further growth in the region.

Notably, the transaction consists of a related party transaction due to Executive Chairman Boris Jordan having a profit interest in the transaction, as well as convertible debentures that represent an 8% interest in the European firm via Measure 8 Ventures.

A total of 16.8 million shares are to be issued in connection with the transaction, representing post-transaction ownership of 3% of Curaleaf. Shares issued will be subject to a lock-up arrangement as well.

The transaction is currently slated to close in the second quarter of 2021, subject to customary conditions and regulatory approval.

Curaleaf Holdings last traded at $20.70 on the CSE.


Information for this briefing was found via Sedar and Curaleaf Holdings. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Silver: The Santa Elena Mine

Equinox Gold: Guidance Cut After Issues At Greenstone

Simply Solventless Q4 Earnings: So Much For Guidance

Recommended

NexGen Energy Receives Approval For Site Expansion At Rook I Project

ESGold Sees Installation Of Humphrey Spirals Completed At Montauban

Related News

Curaleaf Holdings To Raise C$275.6 Million Via Overnight Marketed Offering

Curaleaf Holdings (CSE: CURA) this morning released the pricing of its previously announced overnight marketed...

Thursday, January 7, 2021, 10:14:18 AM

Curaleaf Records $317.1 Million In Q3 2021 Revenue, Net Loss

Curaleaf Holdings (CSE: CURA) this evening reported its third quarter 2021 financial results, posting revenues...

Monday, November 8, 2021, 04:25:03 PM

US Cannabis: Illustrating The Performance Of The Top Four Issuers

The upcoming US election has renewed interest in CSE-listed American cannabis operators, many of which...

Monday, October 26, 2020, 12:30:00 PM

Curaleaf Extends Share Lockups, Reduces Unlock Rate

Major Curaleaf Holdings (CSE: CURA) shareholders have agreed to extended lockups as of this morning,...

Wednesday, January 22, 2020, 08:45:07 AM

Curaleaf: The Analyst Take On The European Expansion

On April 7th, Curaleaf Holdings (CSE: CURA) announced that they completed $312 million acquisition of...

Friday, April 9, 2021, 11:46:00 AM